Jeil Pharmaceutical Co.,Ltd (271980.KS)
KRW 11640.0
(-5.6%)
KRW 11640.0
(-5.6%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -4.98 Billion | -15.14 Billion | 19.1 Billion | -19.04 Billion | 28.95 Billion | 21.45 Billion |
| Net Income | 5 Billion | -15 Billion | -14.98 Billion | 6.96 Billion | -10.58 Billion | 1.88 Billion |
| Depreciation & Amortization | 9.76 Billion | 8.88 Billion | 9.13 Billion | 8.99 Billion | 7.6 Billion | 6.62 Billion |
| Deferred income taxes | -48.21 Billion | - | 8.47 Billion | 3.37 Billion | - | - |
| Stock-based compensation | 578.02 Million | 472.48 Million | 163.16 Million | 80.04 Million | - | - |
| Change in working capital | -20.68 Billion | -15.15 Billion | 14.61 Billion | -39.78 Billion | 21.56 Billion | 7.1 Billion |
| Other non-cash items | 48.56 Billion | 5.65 Billion | 1.7 Billion | 1.32 Billion | 10.37 Billion | 5.82 Billion |
| Investing Cash Flow | -11.91 Billion | -12.92 Billion | -8.03 Billion | -5.57 Billion | -1.14 Billion | -10.4 Billion |
| Investments in PPE | -9.57 Billion | -16.95 Billion | -5.39 Billion | -2.86 Billion | -1.39 Billion | -10.28 Billion |
| Acquisitions | 87.63 Million | 26.01 Billion | -1.49 Billion | 599.99 Million | -307.3 Million | 95.32 Million |
| Investment purchases | -5.55 Billion | -26.01 Billion | -1.9 Billion | -3.54 Billion | -184.99 Million | -350 Million |
| Sales/Maturities of investments | 3.03 Billion | 1.89 Billion | 654.52 Million | 28.23 Million | 350 Million | - |
| Other Investing Activities | 93.8 Million | 2.13 Billion | 109.51 Million | 201.98 Million | 392.03 Million | 228.04 Million |
| Financing Cash Flow | 18.76 Billion | 33.61 Billion | 11.06 Billion | 15.13 Billion | -16.58 Billion | -24.74 Billion |
| Debt repayment | -21.69 Billion | -5.15 Billion | -12.37 Billion | -6.12 Billion | -16.97 Billion | -23.93 Billion |
| Dividends payments | -728.37 Million | -947.73 Million | -1.02 Billion | -1.02 Billion | -875.45 Million | -734.83 Million |
| Common Stock Repurchased | - | -396.98 Million | -810.02 Million | -314.87 Million | -2.99 Billion | -78.55 Million |
| Common Stock Issuance | - | - | -2.21 Billion | 38 Million | - | - |
| Other Financing Activities | 41.19 Billion | 40.11 Billion | 27.49 Billion | 22.55 Billion | 4.25 Billion | - |
| Accounts receivables | -9.9 Billion | -6.04 Billion | 10.64 Billion | 5.16 Billion | 11.8 Billion | 28.29 Billion |
| Accounts payables | -7.61 Billion | -1.66 Billion | 9.62 Billion | -6.48 Billion | 4.79 Billion | -2.07 Billion |
| Inventory | -10.57 Billion | 3.56 Billion | 6.33 Billion | -26.61 Billion | 4.23 Billion | -5.39 Billion |
| Other working capital | 7.4 Billion | -11 Billion | -11.99 Billion | -11.84 Billion | 728.01 Million | 12.49 Billion |
| Cash at beginning of period | 31.44 Billion | 25.96 Billion | 3.89 Billion | 13.51 Billion | 2.49 Billion | 16.2 Billion |
| Cash at end of period | 32.99 Billion | 31.44 Billion | 25.96 Billion | 3.89 Billion | 13.51 Billion | 2.49 Billion |
| Capital Expenditure | -9.57 Billion | -16.95 Billion | -5.39 Billion | -2.86 Billion | -1.39 Billion | -10.28 Billion |
| Effect of forex changes on cash | -321.57 Million | -63.8 Million | -62.03 Million | -131.81 Million | -202.62 Million | -9.35 Million |
| Net cash flow / Change in cash | 1.54 Billion | 5.48 Billion | 22.06 Billion | -9.62 Billion | 11.01 Billion | -13.71 Billion |
| Free Cash Flow | -14.55 Billion | -32.1 Billion | 13.7 Billion | -21.91 Billion | 27.56 Billion | 11.16 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -26.51 Billion | -2.87 Billion | 5 Billion | -2.23 Billion | -4.62 Billion | -1.75 Billion |
| Depreciation & Amortization | 2.9 Billion | 2.67 Billion | 9.76 Billion | 2.59 Billion | 2.38 Billion | 2.45 Billion |
| Deferred income taxes | - | - | -48.21 Billion | -80.92 Million | -48.82 Million | -6.53 Billion |
| Stock-based compensation | - | 213.55 Million | 578.02 Million | 26.69 Million | 233.46 Million | 224.55 Million |
| Change in working capital | -5.19 Billion | -369.59 Million | -20.68 Billion | 11.6 Billion | -15.96 Billion | 12.82 Billion |
| Other non-cash items | 27.9 Billion | 2.03 Billion | 48.56 Billion | 2.06 Billion | 1.41 Billion | 1.23 Billion |
| Investing Cash Flow | -2.27 Billion | -1.73 Billion | -11.91 Billion | 4.25 Billion | -1.85 Billion | -11.05 Billion |
| Investments in PPE | -637.8 Million | -1.89 Billion | -9.57 Billion | -2.52 Billion | -1.82 Billion | -1.95 Billion |
| Acquisitions | 6.35 Million | - | 87.63 Million | 14.63 Million | - | 67 Million |
| Investment purchases | -3.12 Billion | -174.6 Million | -5.55 Billion | 3.77 Billion | -25.8 Million | -9.3 Billion |
| Sales/Maturities of investments | 2.78 Billion | - | 3.03 Billion | 2.88 Billion | - | 142.45 Million |
| Other Investing Activities | -1.63 Billion | 340 Million | 93.8 Million | 92.79 Million | 1 Million | 5.24 Million |
| Financing Cash Flow | 2.21 Billion | -471.29 Million | 18.76 Billion | -11.9 Billion | 9.21 Billion | 13.37 Billion |
| Debt repayment | -546.68 Million | -89.79 Million | -21.69 Billion | -11.26 Billion | -9.77 Billion | -14.57 Billion |
| Dividends payments | -728.37 Million | - | -728.37 Million | - | - | -728.37 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 3.49 Billion | -10.00 | 41.19 Billion | -635.81 Million | 18.98 Billion | 28.68 Billion |
| Accounts receivables | -2.02 Billion | 6.05 Billion | -9.9 Billion | 2.47 Billion | -16.05 Billion | 17.95 Billion |
| Accounts payables | -3.16 Billion | 4.56 Billion | -7.61 Billion | -14.05 Billion | 12.48 Billion | -7.58 Billion |
| Inventory | -3.49 Billion | -6.19 Billion | -10.57 Billion | 16.7 Billion | -10.38 Billion | 337.99 Million |
| Other working capital | 320.12 Million | -4.79 Billion | 7.4 Billion | 6.48 Billion | -2.01 Billion | 2.11 Billion |
| Cash at beginning of period | 31.73 Billion | 32.99 Billion | 31.44 Billion | 27.06 Billion | 36.31 Billion | 25.45 Billion |
| Cash at end of period | 31 Billion | 31.73 Billion | 32.99 Billion | 32.99 Billion | 27.06 Billion | 36.31 Billion |
| Capital Expenditure | -637.8 Million | -1.89 Billion | -9.57 Billion | -2.52 Billion | -1.82 Billion | -1.95 Billion |
| Effect of forex changes on cash | 235.3 Million | 396.45 Million | -321.57 Million | -396.66 Million | -3.16 Million | 85.11 Million |
| Net cash flow / Change in cash | -729.23 Million | -1.26 Billion | 1.54 Billion | 5.92 Billion | -9.24 Billion | 10.86 Billion |
| Free Cash Flow | -1.54 Billion | -1.35 Billion | -14.55 Billion | 11.45 Billion | -18.43 Billion | 6.49 Billion |
000670
CIM
MONEYBOXX
1429
FRS
FIBI